Anebulo Pharmaceuticals, Inc. logo

ANEBAnebulo Pharmaceuticals, Inc.

ANEB Stock Price, Valuation & Chart | Anebulo Pharmaceuticals, Inc.

Compare

ANEB Historical price chart

ANEB Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization12.24M
PE Ratio-1.58
EPS-0.19
Trading Volume100
Today's High/Low0.3/0.3
Dividend Yield0.00
52 Week High/Low2.85/0.0
Shares Outstanding40.78M
ANEB Financial Statement
ANEB Analyst ratings
ANEB Analysis & performance metrics

ANEB Company profile

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid…

ANEB Management team

Management
Daniel V. GeorgeCFO
Acting Chief Financial Officer & Secretary
Richard Anthony CunninghamCEO
Chief Executive Officer & Director
Joseph F. Lawler M.D., Ph.D.
Founder & Chairman
Kenneth C. Cundy Ph.D.
Chief Scientific Officer
Total 4 executives

ANEB Frequently asked questions

What is Anebulo Pharmaceuticals, Inc. (ANEB) Stock Price?

Current stock price of Anebulo Pharmaceuticals, Inc. (ANEB) stock is $0.300. The stock price is -4.76% lower in the session. The intraday range can be seen from this page. Volume of Anebulo Pharmaceuticals, Inc. (ANEB) stock is 100.

Last updated at 02 Sept 2026, 01:50 pm.

Why is the Anebulo Pharmaceuticals, Inc. (ANEB) stock price going up or down today?

The stock price of Anebulo Pharmaceuticals, Inc. (ANEB) can change with earnings, company news, and overall market sentiment. Anebulo Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Anebulo Pharmaceuticals, Inc. stock expensive at its current price?

Whether Anebulo Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ANEB on this page is -1.58. EPS on this page is -0.19. Compare those figures with peers and growth expectations before deciding if the current Anebulo Pharmaceuticals, Inc. price is justified.

How has the stock price of Anebulo Pharmaceuticals, Inc. (ANEB) performed historically?

Historical performance for Anebulo Pharmaceuticals, Inc. (ANEB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ANEB reacted to past earnings and market events.

Should I buy Anebulo Pharmaceuticals, Inc. (ANEB) stock, at this price?

Buying Anebulo Pharmaceuticals, Inc. (ANEB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.